- By significantly improving the analytical sensitivity, which has been a technical challenge of point-of-care testing, the technology enables the investigation of the scale of infection in the community and the epidemiologic investigation of infection without symptoms. It can be applied as a new technology in the antibody diagnosis market in the future.

- Published in Biosensors and Bioelectronics 2022 (JCR 2.87%, Impact factor 10.61), an internationally renowned journal.

The Kwangwoon University research team under the advisory of Prof. Lee Junghoon collaborated with Prof. Yoon Daesung’s team at Korea University, Prof. Yoo Yongkyung's team at Catholic Kwandong University, and Kells Co., Ltd., a diagnostic device venture company. They developed a diagnostic platform that can quickly and accurately analyze the presence or absence of a disease or antibodies on-site by applying the nanoelectrokinetic (NEK) preconcentrator.

<COVID antibody rapid diagnostic device based on nanoelectrokinetic preconcentrator and a lateral flow assay>

This technology is the result of research supported by the National Research Foundation of Korea Biomedical Technology Development Project (No.2021M3E5E3080743) with government funding (Ministry of Science and Technology) in 2021. It was published in Biosensors and Bioelectronics, 2022 (JCR2.87%, Impact factor 10.61), the world's leading biosensor journal.